Indoco Remedies edges higher despite reporting 12.53% fall in Q2 net profit

02 Nov 2012 Evaluate

Indoco Remedies is currently trading at Rs 63.95, up by 0.60 points or 0.95% from its previous closing of Rs 63.35 on the BSE.

The scrip opened at Rs 64.65 and has touched a high and low of Rs 66.45 and Rs 63.95 respectively. So far 21610 shares were traded on the counter.

The BSE group 'B' stock of face value Rs 2 has touched a 52 week high of Rs 83.00 on 04-Sep-2012 and a 52 week low of Rs 50.13 on 03-Nov-2011.

Last one week high and low of the scrip stood at Rs 65.35 and Rs 61.40 respectively. The current market cap of the company is Rs 597.60 crore.

The promoters holding in the company stood at 59.19% while Institutions and Non-Institutions held 16.12% and 24.69% respectively.

Indoco Remedies has reported 12.53% fall in its net profit at Rs 12.08 crore for the quarter ended September 30, 2012 as compared to Rs 13.81 crore for the same quarter in the previous year.  However, total income of the company has increased by 8.22% at Rs 161.98 crore for quarter under review as compared to Rs 149.68 crore for the quarter ended September 30, 2011.

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.

Indoco Remedies Share Price

312.65 -1.50 (-0.48%)
23-May-2024 11:58 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1489.40
Dr. Reddys Lab 5890.45
Cipla 1497.25
Zydus Lifesciences 1092.80
Lupin 1636.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.